AZTA
Price
$47.25
Change
-$1.02 (-2.11%)
Updated
Oct 7, 02:30 PM (EDT)
35 days until earnings call
NEO
Price
$13.94
Change
-$0.00 (-0.00%)
Updated
Oct 4 closing price
22 days until earnings call
Ad is loading...

AZTA vs NEO

Header iconAZTA vs NEO Comparison
Open Charts AZTA vs NEOBanner chart's image
Azenta
Price$47.25
Change-$1.02 (-2.11%)
Volume$1.8K
CapitalizationN/A
NeoGenomics
Price$13.94
Change-$0.00 (-0.00%)
Volume$573.33K
CapitalizationN/A
View a ticker or compare two or three
AZTA vs NEO Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AZTA vs. NEO commentary
Oct 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and NEO is a Hold.

COMPARISON
Comparison
Oct 08, 2024
Stock price -- (AZTA: $48.27 vs. NEO: $13.94)
Brand notoriety: AZTA and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 38% vs. NEO: 83%
Market capitalization -- AZTA: $3.36B vs. NEO: $2.01B
AZTA [@Medical Specialties] is valued at $3.36B. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTA is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 3 bearish.
  • NEO’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than NEO.

Price Growth

AZTA (@Medical Specialties) experienced а -2.25% price change this week, while NEO (@Medical Specialties) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.93%. For the same industry, the average monthly price growth was +4.33%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

AZTA is expected to report earnings on Feb 11, 2025.

NEO is expected to report earnings on Feb 25, 2025.

Industries' Descriptions

@Medical Specialties (-1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than NEO($2.01B). NEO YTD gains are higher at: -13.844 vs. AZTA (-25.898). AZTA has higher annual earnings (EBITDA): 57.5M vs. NEO (-17.61M). AZTA has more cash in the bank: 984M vs. NEO (415M). AZTA has less debt than NEO: AZTA (66.5M) vs NEO (612M). AZTA has higher revenues than NEO: AZTA (641M) vs NEO (592M).
AZTANEOAZTA / NEO
Capitalization3.36B2.01B168%
EBITDA57.5M-17.61M-327%
Gain YTD-25.898-13.844187%
P/E RatioN/A49.50-
Revenue641M592M108%
Total Cash984M415M237%
Total Debt66.5M612M11%
FUNDAMENTALS RATINGS
AZTA vs NEO: Fundamental Ratings
AZTA
NEO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
84100
SMR RATING
1..100
9393
PRICE GROWTH RATING
1..100
6160
P/E GROWTH RATING
1..100
72100
SEASONALITY SCORE
1..100
9585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (66) in the Electronic Production Equipment industry is in the same range as NEO (67) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

AZTA's Profit vs Risk Rating (84) in the Electronic Production Equipment industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

AZTA's SMR Rating (93) in the Electronic Production Equipment industry is in the same range as NEO (93) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

NEO's Price Growth Rating (60) in the Medical Or Nursing Services industry is in the same range as AZTA (61) in the Electronic Production Equipment industry. This means that NEO’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (72) in the Electronic Production Equipment industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that AZTA’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTANEO
RSI
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
73%
Bullish Trend 27 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
73%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSITX64.080.85
+1.34%
Goldman Sachs Small Cp Val Insghts Instl
BACIX14.550.17
+1.18%
BlackRock Energy Opportunities Instl
DLCIX25.710.27
+1.06%
Dana Large Cap Equity Institutional
VITNX98.030.95
+0.98%
Vanguard Instl Ttl Stk Mkt Idx I
TRRSX19.93-0.08
-0.40%
Nuveen Real Estate Sec Sel Retire

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been closely correlated with CRL. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+1.75%
CRL - AZTA
66%
Closely correlated
+0.61%
IQV - AZTA
59%
Loosely correlated
+1.07%
TWST - AZTA
53%
Loosely correlated
+1.29%
RVTY - AZTA
53%
Loosely correlated
-0.11%
TMO - AZTA
53%
Loosely correlated
-0.38%
More